Diabetes pill shows promise in Real-World test
NCT ID NCT05443568
Summary
This study observed how the diabetes medication Rybelsus (oral semaglutide) works for people with type 2 diabetes in everyday medical practice. Researchers followed 155 adults in Israel for 8-10 months to see how the once-daily pill affected their blood sugar levels and body weight. The goal was to collect real-world information on the drug's effectiveness and how satisfied patients were with their treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Master Centre for Israel
Kfar Saba, 44425, Israel
Conditions
Explore the condition pages connected to this study.